Samsung Biologics Stock

Detail	Data
Volume (24h):	50,024 shares
P/E Ratio:	/
Forward P/E:	/
EPS:	/
Forward EPS:	/
Number of Shares:	71,174,000 shares
Market Capitalization:	71,102,822,875,136.00 KRW

The interactive chart displays the price movement of Samsung Biologics shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

Dividend	Value
Dividend Amount	According to our data, the company Samsung Biologics does not currently pay dividends.
Annual Yield %:	-
Ex-dividend Date:	-
5-Year Avg Yield %:	-
Payout Ratio:	-
Last Dividend Value:	-
Last Dividend Date:	-

Analyst Forecast

Most analysts have issued a none recommendation for Samsung Biologics stock. The current number of analysts covering this company is 25. The highest target price is 1600000 KRW, while the lowest target price is 961000 KRW. The median target valuation set by analysts is 1300000 KRW. These forecasts and recommendations provide insight into how analysts view the future stock performance of Samsung Biologics.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for Samsung Biologics stock is: none
Number of Analysts:	25
Highest Target Price:	1600000 KRW
Lowest Target Price:	961000 KRW
Median Target Price:	1300000 KRW

Fundamental Indicators

Indicator	Data
Total Revenue:	4,898,691,743,744.00 KRW
Net Income:	1,279,507,693,568.00 KRW
Price-to-Book (P/B):	/
PEG Ratio:	/
Exchange:	KSE
Industry:	Biotechnology
Sector:	Healthcare
Number of Employees:	4770
Country:	South Korea

Where to Buy Samsung Biologics Stock?

You can purchase Samsung Biologics stock on the KSE under the ticker symbol: 207940.KS. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Samsung Biologics Stock

Indicator	Value
Company Revenue:	4,898,691,743,744.00 KRW
EBITDA:	2,204,527,230,976.00 KRW - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	-
Book Value Per Share:	-
Total Cash:	1,285,235,408,896.00 KRW
Total Cash per Share:	18,057.65 KRW
Total Debt:	1,419,502,813,184.00 KRW
Debt to Equity Ratio:	0.13
Quick Ratio	0.36
Current Ratio	1.45
Free Cash Flow	-707,880,681,472.00 KRW
Operating Cash Flow	2,052,393,664,512.00 KRW
Gross Margins	52.75 %
EBITDA Margins	45.00 %
Operating Margins	37.49 %
Profit Margins	26.12 %
Return on Assets	5.8 %
Return on Equity	12.0 %
Earnings Growth (1 year)	109.4%
Revenue Growth (1 year)	37.1 %
Quarterly Earnings Year-over-Year Growth	109.4 %
Market Capitalization	71,102,822,875,136.00 KRW
Enterprise Value	71,592,960,851,968.00 KRW
EV/Revenue	14.615
EV/EBITDA	32.475
Float Shares	18,158,623 shares
Shares Outstanding	71,174,000 shares
Held Percent Insiders	0.74 %
Held Percent Institutions	14.47 %
Shares Short	-
Shares Short Prior Month	-
Date Short Interest	-
Short Percentage of Total Shares	-
Short Ratio	-
Beta	0.31
Short Percentage of Float	-
Implied Shares Outstanding	72,142,400

Frequently Asked Questions (FAQ)

1️⃣ Does Samsung Biologics pay dividends?

According to our data, the company Samsung Biologics does not pay dividends yet, even in 2025.

2️⃣ Where to buy Samsung Biologics shares?

Samsung Biologics shares are traded on the KSE stock exchange under the ticker: 207940.KS. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for Samsung Biologics shares?

According to our data, the recommendation for Samsung Biologics shares is from a total of 25 analysts. The average target price prediction is 1300000 KRW per share.

4️⃣ What is the total number of shares and the value of Samsung Biologics on the stock exchange?

The total number of Samsung Biologics shares on the exchange is 71,174,000.00 shares, which at the current market capitalization gives the company a total valuation of 71,102,822,875,136.00 KRW.